Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-05

Clinical Trial Update: Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens

View source ↗

Summary

Clinical trial update highlighting efforts to strengthen evidence for optimal multidrug-resistant tuberculosis regimens, including considerations for HIV coinfe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Harvard Medical School (HMS and HSDM) | Conditions: Tuberculosis, Multidrug-Resistant, HIV | Status: ACTIVE_NOT_RECRUITING